Search Results - "Chauvierre, Cédric"

Refine Results
  1. 1

    Nanomedicine progress in thrombolytic therapy by Zenych, Alina, Fournier, Louise, Chauvierre, Cédric

    Published in Biomaterials (01-11-2020)
    “…Thrombotic occlusions of blood vessels are responsible for life-threatening cardiovascular disorders such as myocardial infarction, ischemic stroke, and venous…”
    Get full text
    Journal Article
  2. 2

    Microbubbles for human diagnosis and therapy by Fournier, Louise, de La Taille, Thibault, Chauvierre, Cédric

    Published in Biomaterials (01-03-2023)
    “…Microbubbles (MBs) were observed for the first time in vivo as a curious consequence of quick saline injection during ultrasound (US) imaging of the aortic…”
    Get full text
    Journal Article
  3. 3

    Erythrocyte-Inspired Discoidal Polymeric Nanoconstructs Carrying Tissue Plasminogen Activator for the Enhanced Lysis of Blood Clots by Colasuonno, Marianna, Palange, Anna Lisa, Aid, Rachida, Ferreira, Miguel, Mollica, Hilaria, Palomba, Roberto, Emdin, Michele, Del Sette, Massimo, Chauvierre, Cédric, Letourneur, Didier, Decuzzi, Paolo

    Published in ACS nano (26-12-2018)
    “…Tissue plasminogen activator (tPA) is the sole approved therapeutic molecule for the treatment of acute ischemic stroke. Yet, only a small percentage of…”
    Get full text
    Journal Article
  4. 4

    Thrombolytic therapy based on fucoidan-functionalized polymer nanoparticles targeting P-selectin by Juenet, Maya, Aid-Launais, Rachida, Li, Bo, Berger, Alice, Aerts, Joël, Ollivier, Véronique, Nicoletti, Antonino, Letourneur, Didier, Chauvierre, Cédric

    Published in Biomaterials (01-02-2018)
    “…Injection of recombinant tissue plasminogen activator (rt-PA) is the standard drug treatment for thrombolysis. However, rt-PA shows risk of hemorrhages and…”
    Get full text
    Journal Article
  5. 5

    Fucoidans in Nanomedicine by Chollet, Lucas, Saboural, Pierre, Chauvierre, Cédric, Villemin, Jean-Noël, Letourneur, Didier, Chaubet, Frédéric

    Published in Marine drugs (29-07-2016)
    “…Fucoidans are widespread cost-effective sulfated marine polysaccharides which have raised interest in the scientific community over last decades for their wide…”
    Get full text
    Journal Article Book Review
  6. 6

    REVIEW: “ISCHEMIC STROKE: From Fibrinolysis to Functional Recovery” Nanomedicine: emerging approaches to treat ischemic stroke by Sarfati, Pierre, De La Taille, Thibault, Portioli, Corinne, Spanò, Raffaele, Lalatonne, Yoann, Decuzzi, Paolo, Chauvierre, Cédric

    Published in Neuroscience (09-07-2024)
    “…•Nanoparticles (NPs) are versatile agents to treat all phases of ischemic stroke.•Thrombolysis and neuroprotection can be tackled with nanotechnologies.•Many…”
    Get full text
    Journal Article
  7. 7

    Combining magnetic nanoparticles with cell derived microvesicles for drug loading and targeting by Silva, Amanda K.A., PhD, Luciani, Nathalie, PhD, Gazeau, Florence, PhD, Aubertin, Kelly, PhD, Bonneau, Stéphanie, PhD, Chauvierre, Cédric, PhD, Letourneur, Didier, PhD, Wilhelm, Claire, PhD

    Published in Nanomedicine (01-04-2015)
    “…Abstract Inspired by microvesicle-mediated intercellular communication, we propose a hybrid vector for magnetic drug delivery. It consists of…”
    Get full text
    Journal Article
  8. 8

    rtPA-loaded fucoidan polymer microbubbles for the targeted treatment of stroke by Fournier, Louise, Abioui-Mourgues, Myriam, Chabouh, Georges, Aid, Rachida, Taille, Thibault De La, Couture, Olivier, Vivien, Denis, Orset, Cyrille, Chauvierre, Cédric

    Published in Biomaterials (01-12-2023)
    “…Systemic injection of thrombolytic drugs is the gold standard treatment for non-invasive blood clot resolution. The most serious risks associated with the…”
    Get full text
    Journal Article
  9. 9

    Functionalized polymer microbubbles as new molecular ultrasound contrast agent to target P-selectin in thrombus by Li, Bo, Aid-Launais, Rachida, Labour, Marie-Noëlle, Zenych, Alina, Juenet, Maya, Choqueux, Christine, Ollivier, Véronique, Couture, Olivier, Letourneur, Didier, Chauvierre, Cédric

    Published in Biomaterials (01-02-2019)
    “…Thrombotic diseases rarely cause symptoms until advanced stage and sudden death. Thus, early detection of thrombus by a widely spread imaging modality can…”
    Get full text
    Journal Article
  10. 10

    Fucoidan-functionalized polysaccharide submicroparticles loaded with alteplase for efficient targeted thrombolytic therapy by Zenych, Alina, Jacqmarcq, Charlène, Aid, Rachida, Fournier, Louise, Forero Ramirez, Laura M., Chaubet, Frédéric, Bonnard, Thomas, Vivien, Denis, Letourneur, Didier, Chauvierre, Cédric

    Published in Biomaterials (01-10-2021)
    “…Intravenous administration of fibrinolytic drugs is the standard treatment of acute thrombotic diseases. However, current fibrinolytics exhibit limited…”
    Get full text
    Journal Article
  11. 11

    Polysaccharide nanosystems for future progress in cardiovascular pathologies by Silva, Amanda Karine Andriola, Letourneur, Didier, Chauvierre, Cédric

    Published in Theranostics (01-01-2014)
    “…Natural polysaccharides have received a lot of attention in the biomedical field. Indeed, sources of polysaccharides, extracted or produced from plants,…”
    Get full text
    Journal Article
  12. 12

    The European project NanoAthero to fight cardiovascular diseases using nanotechnologies by Chauvierre, Cédric, Letourneur, Didier

    Published in Nanomedicine (London, England) (01-11-2015)
    “…Cardiovascular diseases are the main causes of death in the world. Nanosystems with contrast agents or drugs appear as promising tools for early detection and…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Enabling MedTech Translation in Academia: Redefining Value Proposition with Updated Regulations by Letourneur, Didier, Joyce, Kieran, Chauvierre, Cédric, Bayon, Yves, Pandit, Abhay

    Published in Advanced healthcare materials (01-01-2021)
    “…Academic institutions are becoming more focused on translating new technologies for clinical applications. A transition from “bench to bedside” is often…”
    Get full text
    Journal Article
  15. 15

    P-selectin targeting polysaccharide-based nanogels for miRNA delivery by Moraes, Fernanda C., Marcelo Forero Ramirez, Laura, Aid, Rachida, Benadda, Samira, Maire, Murielle, Chauvierre, Cédric, Antunes, Joana C., Chaubet, Frédéric, Letourneur, Didier

    Published in International journal of pharmaceutics (15-03-2021)
    “…[Display omitted] Nanogels were prepared in aqueous media without the use of any organic solvent via a simple polyelectrolyte complexation method between…”
    Get full text
    Journal Article
  16. 16

    Synthesis of cationic quaternized pullulan derivatives for miRNA delivery by Moraes, Fernanda C., Antunes, Joana C., Forero Ramirez, Laura Marcela, Aprile, Paola, Franck, Gregory, Chauvierre, Cédric, Chaubet, Frédéric, Letourneur, Didier

    Published in International journal of pharmaceutics (15-03-2020)
    “…[Display omitted] Pullulan is a natural polysaccharide of potential interest for biomedical applications due to its non-toxic, non-immunogenic and…”
    Get full text
    Journal Article
  17. 17

    Development of Polymer Microcapsules Functionalized with Fucoidan to Target P‐Selectin Overexpressed in Cardiovascular Diseases by Li, Bo, Juenet, Maya, Aid‐Launais, Rachida, Maire, Murielle, Ollivier, Véronique, Letourneur, Didier, Chauvierre, Cédric

    Published in Advanced healthcare materials (01-02-2017)
    “…New tools for molecular imaging and targeted therapy for cardiovascular diseases are still required. Herein, biodegradable microcapsules (MCs) made of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Purification of a low molecular weight fucoidan for SPECT molecular imaging of myocardial infarction by Saboural, Pierre, Chaubet, Frédéric, Rouzet, Francois, Al-Shoukr, Faisal, Azzouna, Rana Ben, Bouchemal, Nadia, Picton, Luc, Louedec, Liliane, Maire, Murielle, Rolland, Lydia, Potier, Guy, Guludec, Dominique Le, Letourneur, Didier, Chauvierre, Cédric

    Published in Marine drugs (01-09-2014)
    “…Fucoidans constitute a large family of sulfated polysaccharides with several biochemical properties. A commercial fucoidan from brown algae, containing low…”
    Get full text
    Journal Article